Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Andreas Pollreisz (ORCID: https://orcid.org/0000-0003-3902-239X)
- Oluwatobi O. Idowu (ORCID: https://orcid.org/0000-0003-3269-5719)
- Kara Gibson (ORCID: https://orcid.org/0009-0001-9016-3481)
- Jennifer I. Lim (ORCID: https://orcid.org/0000-0001-7791-6998)
- Avni P. Finn (ORCID: https://orcid.org/0000-0002-7978-4914)
- Timothy Y. Y. Lai (ORCID: https://orcid.org/0000-0002-7832-6428)
- Dilsher S. Dhoot (ORCID: https://orcid.org/0000-0002-1619-452X)
- Paolo Lanzetta (ORCID: https://orcid.org/0000-0003-3746-141X)
- Rahul N. Khurana (ORCID: https://orcid.org/0000-0001-5198-1353)
- Yannan Tang
- Patricio G. Schlottmann (ORCID: https://orcid.org/0000-0003-0196-0452)
- Samantha Fraser‐Bell (ORCID: https://orcid.org/0000-0001-5646-9359)
- Manuel Amador
- Tai-Chi Lin
- Florie A Mar
Institutions
- University of Udine (IT)
- Cleveland Clinic (US)
- Chinese University of Hong Kong (HK)
- Royal North Shore Hospital (AU)
- Sydney Hospital (AU)
- Taipei Veterans General Hospital (TW)
- University of Illinois Chicago (US)
- California Retina Consultants (US)
- Roche (United Kingdom) (GB)
- Retina Vitreous Associates of Florida (US)
- Vanderbilt Health (US)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Ophthalmology Retina
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1016/j.oret.2025.01.017
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.54